BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, April 5, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 7, 2000

View Archived Issues

Ibuprofen as effective as indomethacin in treating patent ductus arteriosus

Read More

Diltiazem and diuretic + beta-blocker display equal efficacy in hypertension trial

Read More

Ditropan XL and Detrol produce similar incidence of dry mouth

Read More

Novel approach to identifying therapeutic targets and high-affinity ligands/substrates

Read More

Discovery of potent alphavbeta3 antagonists described by Merck at ACS meeting

Read More

New phosphodiester analogue synthesized at Duke

Read More

New substituted indolealkanoic acids are potent and selective aldose reductase inhibitors

Read More

DuPont designs potent and selective factor Xa inhibitors with excellent PK profile

Read More

ACS presentation details chemistry, SAR and pharmacology of CV-1013

Read More

Elan/Wyeth-Ayerst describe SAR on series of small-molecule VLA-4/VCAM-1 inhibitors

Read More

Inhaled prostanoids + PDE inhibitors for improving therapy of pulmonary hypertension

Read More

Use of AII receptor antagonists in prevention, treatment of AMI

Read More

FDA approves ciprofloxacin for treatment of postexposure inhalational anthrax

Read More

Pharmacia's Aromasin receives clearance from Health Canada

Read More

Flavopiridol, a known antitumor agent, now reported effective in models of vascular injury

Read More

New JT compounds exert immunostimulating, antiviral and antitumor activity

Read More

Meiji Seika describes inhibitors of PARP and their use in recent patent

Read More

Compositions for pathologies associated with insulin resistance claimed by Merck KGaA

Read More

Teijin reports on new class of factor Xa inhibitors

Read More

New cinnamamide derivatives and their use described by Tsumura

Read More

Nonpeptide agonists of GLP-1 receptor presented by Novo Nordisk and Agouron

Read More

Thrombin inhibitors and their prodrugs synthesized at AstraZeneca

Read More

New heterocyclic CCR5 antagonists from Merck as leads for effective anti-HIV agents

Read More

Bone Care launches Hectorol Injection

Read More

Lundbeck and Mitsui establish citalopram collaboration agreement

Read More

Cantab finalizes DISC-HSV agreement with Glaxo Wellcome

Read More

Acquisition of Spiros by Dura now complete

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 2, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 31, 2026
  • Cancer and blood cells

    Hematopoietic stem cell research points to leukemia’s early roots

    BioWorld Science
    Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
  • Illustration of a nerve cell with DNA double helix

    Molecular signatures show subtypes in neurodegenerative diseases

    BioWorld Science
    Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
  • Antibodies artwork

    More than two to tango: multispecifics at ESMO TAT

    BioWorld Science
    Multispecifics took center stage at this year’s ESMO TAT, emerging as one of the hottest trends in oncology research. Unlike traditional small-molecule drugs or...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing